QR-koodi

Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection

Abstract Background The role of combination therapies for serious methicillin-resistant Staphylococcus aureus (MRSA) infections is widely debated. Methods This retrospective cohort study included adults with MRSA bacteraemia treated between January 1, 2013, to December 31, 2022. Patients receiving c...

Täydet tiedot

Tallennettuna:
Päätekijät: Rami Waked, Leslie Coats, Adriana Rosato, Christina F. Yen, Emily Wood, Daniel J. Diekema, Kristina E. Rokas, Nicholas J. Mercuro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2024-10-01
Sarja:BMC Infectious Diseases
Aiheet:
Staphylococcus aureus
MRSA
Bacteraemia
Vancomycin
Ceftaroline
Endocarditis
Linkit:https://doi.org/10.1186/s12879-024-10107-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia